- Title
- Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma
- Creators - without role
- Lionel Perrier - Groupe d'Analyse et de Théorie Economique Lyon St EtienneAnne Lefranc - Centre Léon BérardPhilippe Quittet - Service d'hématologie et oncologie médicalePhilippe Moreau - Centre Hospitalier Universitaire de NantesCarole Siani - Entrepôts, Représentation et Ingénierie des ConnaissancesHervé Ghesquières - Département HématologieFabrice Jardin - Centre Hospitalier Universitaire de RouenBertrand Favier - Department of PharmacyNorbert Ifrah - Service d'hématologie clinique [Avicenne]Séverine Lissandre - Thion MedicalDavid Pérol - Department of BiostatisticsCatherine Sebban - Centre Léon Bérard
- Publication Details
- Applied Health Economics and Health Policy, Vol.11(2), pp.pp. 129-138
- Identifiers
- 9940322309311
- Academic Unit
- Université de Montpellier
- Language
- English
- Resource Type
- Journal article
- Local Fields
- halshs-00752571
Journal article
Cost-effectiveness of Pegfilgrastim versus Filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma
Applied Health Economics and Health Policy, Vol.11(2), pp.pp. 129-138
2013
Metrics
1 Record Views